ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
386 hedge funds and large institutions have $8.08B invested in Intra-Cellular Therapies Inc. in 2024 Q4 according to their latest regulatory filings, with 69 funds opening new positions, 133 increasing their positions, 138 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
9% more funds holding
Funds holding: 354 → 386 (+32)
4% less repeat investments, than reductions
Existing positions increased: 133 | Existing positions reduced: 138
Holders
386
Holding in Top 10
15
Calls
$25.4M
Puts
$11M
Top Buyers
| 1 | +$40.5M | |
| 2 | +$33M | |
| 3 | +$32.8M | |
| 4 |
D.E. Shaw & Co
New York
|
+$13.6M |
| 5 |
O
OrbiMed
New York
|
+$13.4M |
Top Sellers
| 1 | -$49.3M | |
| 2 | -$39.4M | |
| 3 | -$37.2M | |
| 4 |
PA
Perceptive Advisors
New York
|
-$27.4M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
-$14.9M |